The nuclear localized QKI isoform, QKI-5, has previously been shown to influence mesenchymal features of breast cancer cells, including promoting an elongated cell morphology, increasing cell migration, and facilitating a mesenchymal alternative splicing program (Li et al., 2018; Pillman et al., 2018). Here, QKI is linked to breast cancer.